• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Liver protein synthesis stays elevated after chemotherapy in tumour-bearing mice.

作者信息

Samuels Sue E, McLaren Teresa A, Knowles Andrew L, Stewart Sarah A, Madelmont Jean-Claude, Attaix Didier

机构信息

Food, Nutrition & Health, The University of British Columbia, Vancouver, BC, Canada V6T 1Z4.

出版信息

Cancer Lett. 2006 Jul 28;239(1):78-83. doi: 10.1016/j.canlet.2005.07.026. Epub 2005 Sep 2.

DOI:10.1016/j.canlet.2005.07.026
PMID:16140458
Abstract

We studied the effect of chemotherapy on liver protein synthesis in mice bearing colon 26 adenocarcinoma (C26). Liver protein mass decreased (-32%; P<0.05) in cachectic mice, but protein synthesis increased (20-35%; P<0.05) in cachectic mice, which is consistent with increased export protein synthesis. Increased protein synthesis in tumour-bearing mice was primarily mediated by increasing ( approximately 15%; P<0.05) the RNA concentration, i.e. the capacity for protein synthesis (Cs; mg RNA/g protein). Cystemustine, a nitrosourea chemotherapy that cures C26 with 100% efficacy, rapidly restored liver protein mass; protein synthesis however stayed higher than in healthy mice ( approximately 15%) throughout the initial and later stages of recovery. Chemotherapy had no significant effect on liver protein mass and synthesis in healthy mice. Reduced food intake was not a factor in this model. These data suggest a high priority for liver protein synthesis during cancer cachexia and recovery.

摘要

相似文献

1
Liver protein synthesis stays elevated after chemotherapy in tumour-bearing mice.
Cancer Lett. 2006 Jul 28;239(1):78-83. doi: 10.1016/j.canlet.2005.07.026. Epub 2005 Sep 2.
2
Protein metabolism in the small intestine during cancer cachexia and chemotherapy in mice.小鼠癌症恶病质和化疗期间小肠中的蛋白质代谢
Cancer Res. 2000 Sep 1;60(17):4968-74.
3
Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis.化疗可抑制骨骼肌中泛素 - 蛋白酶体依赖性蛋白水解。
Cancer Res. 2002 May 15;62(10):2771-7.
4
Higher skeletal muscle protein synthesis and lower breakdown after chemotherapy in cachectic mice.恶病质小鼠化疗后骨骼肌蛋白合成增加且分解减少。
Am J Physiol Regul Integr Comp Physiol. 2001 Jul;281(1):R133-9. doi: 10.1152/ajpregu.2001.281.1.R133.
5
Protein synthesis measured in vivo in muscle and liver of cachectic tumor-bearing mice.在恶病质荷瘤小鼠的肌肉和肝脏中进行的体内蛋白质合成测定。
Cancer Res. 1984 Jul;44(7):2779-84.
6
Erythropoietin attenuates cachectic events and decreases production of interleukin-6, a cachexia-inducing cytokine.促红细胞生成素可减轻恶病质相关症状,并减少白细胞介素-6(一种可诱导恶病质的细胞因子)的产生。
Cytokine. 2005 Dec 7;32(5):234-9. doi: 10.1016/j.cyto.2005.10.002. Epub 2005 Dec 9.
7
Nucleoside analogues: 8. Some isomers of B.3839, the original 5-fluorouracil/nitrosourea molecular combination, and their effect on colon, breast and lung tumours in mice.
Anticancer Drug Des. 1989 Jun;4(1):1-20.
8
Catabolic factors in cancer cachexia.癌症恶病质中的分解代谢因素。
In Vivo. 1996 Mar-Apr;10(2):131-6.
9
[Effect of N-alkyl-N-nitrosourea on the protein-synthesizing system of liver and hepatoma 22a cells].[N-烷基-N-亚硝基脲对肝脏及肝癌22a细胞蛋白质合成系统的影响]
Biull Eksp Biol Med. 1973 Oct;75(10):51-4.
10
Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice.向小鼠中枢输注黑皮质素受体拮抗剂刺鼠相关肽(AgRP(83 - 132))可预防由辐射和结肠26肿瘤诱导的恶病质相关症状。
Peptides. 2007 Mar;28(3):636-42. doi: 10.1016/j.peptides.2006.11.021. Epub 2007 Jan 3.

引用本文的文献

1
Pre-cachectic changes in amino acid homeostasis precede activation of eIF2α signaling in the liver at the onset of C26 cancer-induced cachexia.在C26癌症诱导的恶病质发生时,氨基酸稳态的恶病质前期变化先于肝脏中eIF2α信号的激活。
iScience. 2025 Feb 14;28(3):112030. doi: 10.1016/j.isci.2025.112030. eCollection 2025 Mar 21.
2
Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments.靶向激活素受体信号通路以对抗癌症及其治疗的多系统并发症。
Cells. 2021 Feb 28;10(3):516. doi: 10.3390/cells10030516.
3
Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses.
使用可溶性 ACVR2B 治疗恶病质可提高存活率,改变 mTOR 定位,并减轻肝脏和脾脏反应。
J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):514-529. doi: 10.1002/jcsm.12310. Epub 2018 May 2.
4
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia.携带结肠26癌的荷瘤小鼠作为癌症恶病质研究模型。
J Vis Exp. 2016 Nov 30(117):54893. doi: 10.3791/54893.
5
Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.在小鼠中对诱导癌症恶病质的 C26 结肠癌细胞的分子、细胞和生理学特征进行分析。
BMC Cancer. 2010 Jul 8;10:363. doi: 10.1186/1471-2407-10-363.